Document is current
Any future updates will be listed below
-
Authors
Nahas, Stephanie J.
Hindiyeh, Nada
Friedman, Deborah I.
Elbuluk, Nada
Kellerman, Donald J. https://orcid.org/0000-0002-0789-5877
Foreman, Pamela K.
Schmidt, Peter
- License Information
-
More Information
Article History
Received: 28 December 2020
Accepted: 26 April 2021
First Online: 17 May 2021
Declarations
:
: The protocol was approved by the Copernicus (Cary, NC) and individual investigator site Institutional Review Boards. Potential participants provided written informed consent.
: All authors have provided their consent for publication.
: Dr. Nahas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder/Lundbeck, Allergan/AbbVie, Amgen/Novartis, Biohaven, electroCore, Eli Lilly, Impel, Supernus, Teva, Theranica, Zosano Pharma. She receives author/editor honoraria/royalties from Springer and Wolters-Kluwer.Dr. Hindiyeh serves on advisory boards for Amgen, Eli Lilly, Lundbeck and Zosano Pharma.Dr. Friedman serves on advisory boards for Allergan, Amgen, Biohaven Biopharmaceuticals, electroCore, Eli Lilly, Impel, Invex, Lundbeck, Revance, Supernus, Teva, Theranica and Zosano. She receives grant support from Allergan, Eli Lilly, Merck and Zosano. She receives honoraria for serving as a contributing author to MedLink Neurology and Medscape and as a member of the Editorial Board of Neurology Reviews.Dr. Elbuluk serves on an advisory board for Avita and Galderma. Consultant with Visual Dx and Zosano Pharma.Dr. Foreman is a consultant for Zosano Pharma.Dr. Kellerman is a current employee and Dr. Schmidt is a former employee and consultant of Zosano Pharma.
